Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440–9
Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440–9. // British Journal of Anaesthesia. – URL: https://www.sciencedirect.com/science/article/pii/S0007091226006045?dgcid=rss_sd_all
Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440–9. British Journal of Anaesthesia. https://www.sciencedirect.com/science/article/pii/S0007091226006045?dgcid=rss_sd_all
“Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440–9.” British Journal of Anaesthesia.
@article{article39161,
title = {Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440–9},
journal = {British Journal of Anaesthesia},
url = {https://www.sciencedirect.com/science/article/pii/S0007091226006045?dgcid=rss_sd_all}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...